EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Structural and Immunoreactivity Properties of the SARS-CoV-2 Spike Protein upon the Development of an Inactivated Vaccine

Larisa V Kordyukova iD, Andrey V Moiseenko, Marina V Serebryakova, Marina A Shuklina iD, Maria V Sergeeva iD, Dmitry A Lioznov, Andrei V Shanko iD

Viruses · 2023

DOI: 10.3390/v15020480 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Larisa V Kordyukova und 6 weiteren Autor:innen. Beteiligte Einrichtung: Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119991 Moscow, Russia. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, COVID-19. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Foundation for Basic Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inactivated vaccines are promising tools for tackling the COVID-19 pandemic. We applied several protocols for SARS-CoV-2 inactivation (by β-propiolactone, formaldehyde, and UV radiation) and examined the morphology of viral spikes, protein composition of the preparations, and their immunoreactivity in ELISA using two panels of sera collected from convalescents and people vaccinated by Sputnik V. Transmission electron microscopy (TEM) allowed us to distinguish wider flail-like spikes (supposedly the S-protein’s pre-fusion conformation) from narrower needle-like ones (the post-fusion state). While the flails were present in all preparations studied, the needles were highly abundant in the β-propiolactone-inactivated samples only. Structural proteins S, N, and M of SARS-CoV-2 were detected via mass spectrometry. Formaldehyde and UV-inactivated samples demonstrated the highest affinity/immunoreactivity against the convalescent sera, while β-propiolactone (1:2000, 36 h) and UV-inactivated ones were more active against the sera of people vaccinated with Sputnik V. A higher concentration of β-propiolactone (1:1000, 2 h) led to a loss of antigenic affinity for both serum panels. Thus, although we did not analyze native SARS-CoV-2 for biosafety reasons, our comparative approach helped to exclude some destructive inactivation conditions and select suitable variants for future animal research. We believe that TEM is a valuable tool for inactivated COVID-19 vaccine quality control during the downstream manufacturing process.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spike Glycoprotein, CoronavirusCOVID-19AnimalsHumansVaccines, InactivatedCOVID-19 SerotherapyCOVID-19 VaccinesPandemicsPropiolactoneSARS-CoV-2Formaldehyde

Stichwörter der Autor:innen

ELISAMALDI-TOF mass spectrometryS proteinSARS-CoV-2 inactivationUV irradiationformaldehydeimmunoreactivitypost-fusionpre-fusiontransmission electron microscopyβ-propiolactone

Substanzen

spike protein, SARS-CoV-2Spike Glycoprotein, CoronavirusVaccines, InactivatedCOVID-19 VaccinesPropiolactoneFormaldehyde

Autor:innen und Institutionen

  • Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119991 Moscow, Russia.
  • Faculty of Biology, Lomonosov Moscow State University, 119991 Moscow, Russia.
  • WHO National Influenza Center, Smorodintsev Research Institute of Influenza, 197376 Saint-Petersburg, Russia.
  • R&D Department, FORT LLC, 119435 Moscow, Russia.

ORCID-Profile: Larisa V Kordyukova, Marina A Shuklina, Maria V Sergeeva, Andrei V Shanko

Förderung

  • Russian Foundation for Basic Research

Zitieren

APA

Kordyukova, L. V., Moiseenko, A. V., Serebryakova, M. V., Shuklina, M. A., Sergeeva, M. V., Lioznov, D. A., & Shanko, A. V. (2023). Structural and Immunoreactivity Properties of the SARS-CoV-2 Spike Protein upon the Development of an Inactivated Vaccine. Viruses. https://doi.org/10.3390/v15020480

Vancouver

Kordyukova LV, Moiseenko AV, Serebryakova MV, Shuklina MA, Sergeeva MV, Lioznov DA, et al. Structural and Immunoreactivity Properties of the SARS-CoV-2 Spike Protein upon the Development of an Inactivated Vaccine. Viruses. 2023. doi:10.3390/v15020480

BibTeX
@article{Kordyukova2023,
  author = {Kordyukova, Larisa V and Moiseenko, Andrey V and Serebryakova, Marina V and Shuklina, Marina A and Sergeeva, Maria V and Lioznov, Dmitry A and Shanko, Andrei V},
  title = {Structural and Immunoreactivity Properties of the SARS-CoV-2 Spike Protein upon the Development of an Inactivated Vaccine},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15020480}
}
Kostenlos starten →